Accurately tracks the return of bowel activity following abdominal surgery to potentially allow for
earlier hospital discharge. Technology also has potential to monitor response to medications in
chronic bowel conditions such as irritable bowel syndrome (IBS).
Optimisation of prototype and maximisation of usability: clinical studies.
The NHS manages over 24 million mental health appointments each year, yet time-consuming
administrative tasks restrict clinicians to just 1.5 patient contacts per day. Anathem has the potential to free up valuable time, enabling up to 12 million additional appointments by streamlining admin processes and in turn, reducing long waiting lists.
Evaluation and piloting in a real-world setting, understanding procurement frameworks and processes for scaling.
Securing funding for market access and developing international distribution channels
130,000 bloodstream infections (BSIs) are detected in the UK annually. If left untreated, these
infections can quickly escalate to sepsis, septic shock, and ultimately, death.
Alarmingly, 1 in 10 patients is infected with bacteria that do not respond to commonly used
antibiotics. Yet, clinicians currently have no way to rapidly determine whether a prescribed
antibiotic will be effective. As a result, mortality rates increase by 4-7% for every hour that effective
treatment is delayed. Current laboratory methods take at least two days to identify the right
antibiotic, underscoring the urgent need for faster diagnostic solutions.
Manufacturing, systems engineering, data analysis and regulatory compliance
There is an abundance of health data that can be leveraged to produce real-world evidence and other clinical insights. However, there are difficulties using data which leads to outcomes that are
rarely reproducible, expensive, and time-consuming. For example, a typical epidemiology study using primary care data would typically take 6-12 months. Dexter reduces the time taken for the extraction of insights from months to minutes.
Scaling beyond the initial demonstrator sites
This affordable, non-invasive device addresses an unmet clinical need for 70 million patients
worldwide. Patients with pDPN endure debilitating lower limb pain, severely impacting mobility,
sleep, and quality of life. A 10-day Sensetic treatment delivers months of pain relief, improving
clinical outcomes and reducing the burden to health and social care system.
Clinical trial leadership and scoping, identifying supply chain and high-volume manufacturing in the
West Midlands, support to access global markets
This racially inclusive and movement-resistant technology enables continuous monitoring of vital
signs, supports digital blood pressure measurement, and facilitates both individual disease
management and large-scale population health insights.
Access to grant funding and support in navigating a complex and evolving regulatory landscape
Empowers users with disabilities by enhancing comfort, promoting postural health, and providing
a long-term, cost-effective seating solution. With its versatility, durability, and focus on
individualised support, Trixi seating empowers children with special needs to engage comfortably
in various activities, both indoors and outdoors.
Regulatory compliance and scale up
Retained surgical swabs are the single most common, yet underreported ‘never
event’ during surgeries, causing serious health complications and legal costs. Manual counting is prone to human
error, particularly in high-pressure surgeries.
Stakeholder engagement and wider adoption
Currently the only way to perform a full cervical smear test is with a speculum – a medical device
that has seen little innovation over the last 150 years. Nearly 1 in 4 women the UK are failing to
accept their screening invitations due to embarrassment and pain. This product could radically
enhance the current screening process, reducing patient mortality and improving service to
underserved communities.
Prototype development and validation in a clinical environment
Using patented RE-EXPAR DNA amplification, the technology enables rapid, self-collected testing
with a disposable cartridge, allowing diagnosis and treatment in a single visit. Future capabilities
to include screening for antibiotic resistance.
Overcoming technical challenges and stakeholder engagement
Automatically determining an optimised set of medications for an individual patient by
algorithmically distilling the recommendations from dozens of different medical guidelines –
enhancing precision and efficiency for clinicians.
Clinical evaluation and funding
Pulse oximeters underestimate Oxygen saturation (SpO₂) in Black patients. Vichag’s Hypoxia Lab
provided diverse datasets to enhance SmartOx accuracy. Access to high-quality, varied clinical
data is vital for Software as Medical Device (SaMD) and imaging research – which Vichag enable
through their sites in UK, India, and the US.
Business development to secure research projects and negotiate intellectual property terms
Privacy Policy · Terms and Conditions · Governance
